Category:
Description:
Indications:
-
Mild
or transient episodes of heart block and Stokes-Adams attacks (except
when caused by ventricular tachycardia or fibrillation)
-
Cardiac
arrest (until electric shock or pacemaker is available)
-
Bronchospasm
occurring during anesthesia, asthma, chronic bronchitis, or emphysema
-
Hypovolemic
and septic shock, low cardiac output states, CHF, cardiogenic shock
Contraindications:
-
Tachydysrhythmias,
tachycardia or heart block caused by digitalis intoxication
-
Ventricular
dysrhythmias requiring inotropic therapy, angina pectoris
Precautions:
-
Pregnancy
category C
-
Hypovolemia,
coronary artery disease, coronary insufficiency
-
Diabetes,
hyperthyroidism
Adverse
Reactions (Side Effects):
-
CNS:
anxiety, dizziness, headache, mild tremors, nervousness, weakness
-
CV:
angina, hypertension, hypotension, palpitations, tachycardia,
tachydysrhythmias, ventricular dysrhythmias
-
GI:
nausea, vomiting
-
RESP:
pulmonary edema
-
SKIN:
flushing of skin, sweating
|
Dosage:
Administered
orally (inhalation via solution and aerosol), intravenously,
intramuscularly, subcutaneously
-
Adult:
-
Bronchospasm:
-
MDI
1-2 puffs 4-6 times daily
-
NEB
0.25-0.5ml of a 1% solution diluted in 2-3ml normal saline or
0.25% and 0.5% undiluted, treatment may be repeated up to 5
times daily
-
Dysrhythmia/heart
block:
-
IV
0.02-0.06mg (1-3ml of 1:50,000 dilution) bolus, followed by
subsequent doses of 0.01-0.2mg (0.5-10ml op 1:50,000 dilution)
-
IV
INF 5 mcg/min initially, titrate to desired response, usual
range 2-20 mcg/min
-
IM
0.2mg (1ml of 1:5,000 dilution) initially, subsequent doses of
0.02-1mg (0.1-5ml of 1:5,000 dilution)
-
SC
0.2mg (1ml of 1:5,000 dilution) initially, subsequent doses of
0.15-0.2mg (0.75-1ml of 1:5,000 dilution)
-
IC
0.02mg (0.1ml of 1:5,000 dilution)
-
Shock:
-
Child:
|
|
|
|
The information contained here is an
abbreviated summary. For more detailed and complete information, consult the
manufacturer's product information sheets or standard textbooks
Source: Operational Medicine 2001, Health
Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau
of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington,
D.C., 20372-5300
This information is provided by The Brookside Associates. The Brookside
Associates, LLC. is a private organization, not affiliated with any governmental
agency. The opinions presented here are those of the author and do not
necessarily represent the opinions of the Brookside Associates or the Department
of Defense. The presence of any advertising on these pages does not constitute
an endorsement of that product or service by either the US Department of Defense
or the Brookside Associates. All material presented here is unclassified.
C. 2009, 2014, All Rights Reserved
|
|